Summary
- Current Price
- As of today, LXEO price is $4.65, up +6.41% on
- Current Price All-Time High
- LXEO price is currently -79.18% below its historical high of $22.33 set on
- Market Cap
- LXEO current market cap is $365M, up +179.20% over the past 365 days
- PE Ratio
- LXEO PE ratio is unknown
- Revenue
- LXEO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for LXEO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Lexeo Therapeutics, Inc. |
| Ticker | NASDAQ: LXEO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lexeotx.com |
| Employees | 75 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.65 | |
| Price, 1D Change | +6.41% | |
| $365M | ||
| - | ||
| - | ||
| 2.02 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.86 | ||
| EPS, 1Y Change | +39.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.86 | ||
| EPS Estimate | N/A | -$1.14 |
| EPS Est. Change | N/A | +39.09% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $4.65 | |
| Price Target | - | $19.50 |
| Price Tgt. Change | - | +319.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.09 | -$3.09 | -0.16% | |
| -$1.92 | -$1.86 | +3.06% | |
| -$1.14 | N/A | +39.09% | |
| -$1.31 | N/A | +29.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $7.68M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.65 | |
| $7.14 | ||
| $5.53 | ||
| - | ||
| - | ||
| - | ||
| 2.02 | ||
| $0.36 | ||
| 38.61 | ||
| 76.64% | ||
| 78.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.86 | ||
| -$2.08M | ||
| - | ||
| -$109.26M | ||
| - | ||
| -$99.96M | ||
| - | ||
| -$107.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 11.21 | ||
| 11.21 | ||
| - | ||
| - | ||
| 6.42 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.58 | ||
| -1.88 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $246.67M | ||
| $181.77M | ||
| $271.13M | ||
| $188.39M | ||
| $24.46M | ||
| $16.81M | ||
| $7.89M | ||
| $2.68M | ||
| $4.86M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $99.96M | ||
| $107.18M | ||
| $2.08M | ||
| $0.00 | ||
| $2.08M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$98.56M | ||
| -$90.25M | ||
| $216.80M | ||
| $397.00K | ||
| -$98.96M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Raymond James | ||
| Chardan Capital | → | |
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with LXEO
FAQ
What is the ticker symbol for Lexeo Therapeutics, Inc.?
The ticker symbol for Lexeo Therapeutics, Inc. is NASDAQ:LXEO
Does Lexeo Therapeutics, Inc. pay dividends?
No, Lexeo Therapeutics, Inc. does not pay dividends
What sector is Lexeo Therapeutics, Inc. in?
Lexeo Therapeutics, Inc. is in the Healthcare sector
What industry is Lexeo Therapeutics, Inc. in?
Lexeo Therapeutics, Inc. is in the Biotechnology industry
What country is Lexeo Therapeutics, Inc. based in?
Lexeo Therapeutics, Inc. is headquartered in United States
When did Lexeo Therapeutics, Inc. go public?
Lexeo Therapeutics, Inc. initial public offering (IPO) was on November 3, 2023
Is Lexeo Therapeutics, Inc. in the S&P 500?
No, Lexeo Therapeutics, Inc. is not included in the S&P 500 index
Is Lexeo Therapeutics, Inc. in the NASDAQ 100?
No, Lexeo Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Lexeo Therapeutics, Inc. in the Dow Jones?
No, Lexeo Therapeutics, Inc. is not included in the Dow Jones index
When was Lexeo Therapeutics, Inc. last earnings report?
Lexeo Therapeutics, Inc.'s most recent earnings report was on May 11, 2026
When does Lexeo Therapeutics, Inc. report earnings?
The next expected earnings date for Lexeo Therapeutics, Inc. is August 13, 2026
Data Sources & References
- LXEO Official Website www.lexeotx.com
- LXEO Profile on Yahoo Finance finance.yahoo.com/quote/LXEO
- LXEO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lxeo